{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:16:04Z","timestamp":1772601364948,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173825"],"award-info":[{"award-number":["82173825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773740"],"award-info":[{"award-number":["81773740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.intimp.2026.116342","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T23:40:41Z","timestamp":1771198841000},"page":"116342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of ROCK2 impedes osteoclastogenesis through Src-Ca2+-NFATc1 signaling pathway and alleviates ovariectomy-induced bone loss"],"prefix":"10.1016","volume":"174","author":[{"given":"Qin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiehuang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116342_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108168","article-title":"Advances in pathogenesis and therapeutic strategies for osteoporosis","volume":"237","author":"Song","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2026.116342_bb0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","article-title":"Long-term and sequential treatment for osteoporosis","volume":"19","author":"Foessl","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0015","article-title":"FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized mice","volume":"16","author":"Xie","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1172\/JCI77186","article-title":"Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling","volume":"125","author":"Menendez-Gutierrez","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-022-00371-3","article-title":"Osteoporosis pathogenesis and treatment: existing and emerging avenues","volume":"27","author":"Liang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.intimp.2026.116342_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jare.2023.09.001","article-title":"Irisin as an agent for protecting against osteoporosis: a review of the current mechanisms and pathways","volume":"62","author":"Hu","year":"2024","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-pathmechdis-031521-040919","article-title":"Osteoclasts, master sculptors of bone","volume":"18","author":"Veis","year":"2023","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116342_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14041138","article-title":"Osteoporosis and rheumatoid arthritis: mechanisms underlying osteoclast differentiation and activation or factors associated with hip fractures","volume":"14","author":"Miyamoto","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/25785826.2023.2220931","article-title":"Osteoclast differentiation in rheumatoid arthritis","volume":"47","author":"Yokota","year":"2024","journal-title":"Immunol Med."},{"key":"10.1016\/j.intimp.2026.116342_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1401113","article-title":"Molecular mechanism of bone metastasis in breast cancer","volume":"14","author":"Sui","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116342_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jare.2024.03.021","article-title":"Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction","volume":"69","author":"Zheng","year":"2025","journal-title":"J. Adv. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116342_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137045","article-title":"JAK2-IGF1 axis in osteoclasts regulates postnatal growth in mice","volume":"6","author":"Dodington","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2026.116342_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110316","article-title":"Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos\/NFATc1 signaling","volume":"120","author":"Yang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"13","key":"10.1016\/j.intimp.2026.116342_bb0070","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.244798","article-title":"The osteoclast cytoskeleton - current understanding and therapeutic perspectives for osteoporosis","volume":"133","author":"Blangy","year":"2020","journal-title":"J. Cell Sci."},{"issue":"6937","key":"10.1016\/j.intimp.2026.116342_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2009.00821.x","article-title":"Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation","volume":"231","author":"Negishi-Koga","year":"2009","journal-title":"Immunodefic. Rev."},{"key":"10.1016\/j.intimp.2026.116342_bb0085","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1111\/j.1749-6632.2011.06373.x","article-title":"New regulation mechanisms of osteoclast differentiation","volume":"1240","author":"Nakashima","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2026.116342_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcp.2016.10.007","article-title":"Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLC\u03b31-Ca2+-NFATc1 signaling pathway and prevents ovariectomy-induced bone loss","volume":"124","author":"Zeng","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0095","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1038\/cddis.2013.10","article-title":"Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment","volume":"4","author":"Shi","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1159\/000492994","article-title":"Distinct roles for ROCK1 and ROCK2 in the regulation of Oxldl-mediated endothelial dysfunction","volume":"49","author":"Huang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2026.116342_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000502914","article-title":"Distinct roles of ROCK1 and ROCK2 on the cerebral ischemia injury and subsequently neurodegenerative changes","volume":"105","author":"Lu","year":"2020","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.intimp.2026.116342_bb0110","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.37934","article-title":"Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus","volume":"65","author":"Isgro","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/pr.114.009381","article-title":"The rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis","volume":"67","author":"Knipe","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"17","key":"10.1016\/j.intimp.2026.116342_bb0120","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","article-title":"Targeted rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism","volume":"127","author":"Flynn","year":"2016","journal-title":"Blood"},{"issue":"32","key":"10.1016\/j.intimp.2026.116342_bb0125","doi-asserted-by":"crossref","first-page":"E6603","DOI":"10.1073\/pnas.1706011114","article-title":"Rho-associated kinase is a therapeutic target in neuroblastoma","volume":"114","author":"Dyberg","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.intimp.2026.116342_bb0130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/oncolo\/oyac076","article-title":"Recent FDA approvals in the treatment of graft-versus-host disease","volume":"27","author":"Martini","year":"2022","journal-title":"Oncologist"},{"issue":"47","key":"10.1016\/j.intimp.2026.116342_bb0135","doi-asserted-by":"crossref","first-page":"16814","DOI":"10.1073\/pnas.1414189111","article-title":"Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism","volume":"111","author":"Zanin-Zhorov","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.intimp.2026.116342_bb0140","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1007\/s11030-024-11054-w","article-title":"Discovery of selective ROCK2 inhibitors with free radical scavenging ability for the treatment of gouty arthritis","volume":"29","author":"Cao","year":"2025","journal-title":"Mol. Divers."},{"issue":"22","key":"10.1016\/j.intimp.2026.116342_bb0145","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1021\/acs.jmedchem.3c01297","article-title":"Design, synthesis, and biological evaluation of an orally bioavailable, potent, and selective ROCK2 inhibitor for psoriasis treatment","volume":"66","author":"Huang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cellsig.2014.11.012","article-title":"High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway","volume":"27","author":"Cheng","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2026.116342_bb0155","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CMAR.S279496","article-title":"ROCK2 promotes osteosarcoma growth and glycolysis by up-regulating HKII via Phospho-PI3K\/AKT signalling","volume":"13","author":"Deng","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s10020-023-00638-1","article-title":"RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling","volume":"29","author":"Wang","year":"2023","journal-title":"Mol. Med."},{"issue":"12","key":"10.1016\/j.intimp.2026.116342_bb0165","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1359\/jbmr.2003.18.12.2159","article-title":"12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-\u03baB activation","volume":"18","author":"Wang","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1042\/BJ20121626","article-title":"HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors","volume":"451","author":"van der Kraan","year":"2013","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.intimp.2026.116342_bb0175","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-21-4176","article-title":"FDA approval summary: Belumosudil for adult and pediatric patients 12 years and older with chronic GVHD after two or more prior lines of systemic therapy","volume":"28","author":"Przepiorka","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/14728222.2011.546351","article-title":"Therapeutic targeting of osteoclast function and pathways","volume":"15","author":"Broadhead","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-11-0132","article-title":"Osteoblasts in osteoporosis: past, emerging, and future anabolic targets","volume":"165","author":"Marie","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116342_bb0190","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0195","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jcp.24723","article-title":"Regulation of osteoclast multinucleation by the actin cytoskeleton signaling network","volume":"230","author":"Takito","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0945-053X(00)00051-2","article-title":"Integrins and signaling in osteoclast function","volume":"19","author":"Duong","year":"2000","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116342_bb0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00774-007-0773-9","article-title":"Involvement of \u03b1v\u03b23 integrins in osteoclast function","volume":"25","author":"Nakamura","year":"2007","journal-title":"J. Bone Miner. Metab."},{"issue":"5","key":"10.1016\/j.intimp.2026.116342_bb0210","doi-asserted-by":"crossref","first-page":"F571","DOI":"10.1152\/ajprenal.00113.2014","article-title":"Rho-kinase regulation of TNF-\u03b1-induced nuclear translocation of NF-\u03baB RelA\/p65 and M-CSF expression via p38 MAPK in mesangial cells","volume":"307","author":"Matoba","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116342_bb0215","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41419-021-03939-7","article-title":"A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF\u03baB pathways","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbrc.2006.10.011","article-title":"Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway","volume":"351","author":"Huang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2026.116342_bb0225","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jbmr.3655","article-title":"The novel p38 inhibitor, Pamapimod, inhibits osteoclastogenesis and counteracts estrogen-dependent bone loss in mice","volume":"34","author":"Zhao","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"6406","key":"10.1016\/j.intimp.2026.116342_bb0230","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/360741a0","article-title":"Bone and haematopoietic defects in mice lacking c-fos","volume":"360","author":"Wang","year":"1992","journal-title":"Nature"},{"issue":"5184","key":"10.1016\/j.intimp.2026.116342_bb0235","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"C-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.intimp.2026.116342_bb0240","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bone.2006.11.005","article-title":"Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation","volume":"40","author":"Bakiri","year":"2007","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.intimp.2026.116342_bb0245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","article-title":"Regulation of NFATc1 in osteoclast differentiation","volume":"21","author":"Kim","year":"2014","journal-title":"J Bone Metab."},{"issue":"6","key":"10.1016\/j.intimp.2026.116342_bb0250","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.intimp.2026.116342_bb0255","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jbmr.4478","article-title":"Myeloid-specific PTP1B deficiency attenuates inflammation-induced and ovariectomy-induced bone loss in mice by inhibiting osteoclastogenesis","volume":"37","author":"Kim","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"22","key":"10.1016\/j.intimp.2026.116342_bb0260","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1074\/jbc.M112.358796","article-title":"Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF\u03baB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway","volume":"287","author":"Tomomura","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.116342_bb0265","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/s10165-006-0460-z","article-title":"The role of c-Src kinase in the regulation of osteoclast function","volume":"16","author":"Miyazaki","year":"2006","journal-title":"Mod. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116342_bb0270","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1073\/pnas.90.10.4485","article-title":"Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts","volume":"90","author":"Lowe","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5 Pt A","key":"10.1016\/j.intimp.2026.116342_bb0275","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.bbagen.2017.02.005","article-title":"Functions of Rho family of small GTPases and Rho-associated coiled-coil kinases in bone cells during differentiation and mineralization","volume":"1861","author":"Strzelecka-Kiliszek","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0280","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2010.10.006","article-title":"The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating rho-kinase 2","volume":"140","author":"Wong","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2026.116342_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153838","article-title":"Dendrobine attenuates osteoclast differentiation through modulating ROS\/NFATc1\/ MMP9 pathway and prevents inflammatory bone destruction","volume":"96","author":"Deng","year":"2022","journal-title":"Phytomedicine"},{"issue":"18","key":"10.1016\/j.intimp.2026.116342_bb0290","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1111\/bph.15179","article-title":"A marine fungus-derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF\u03baB ligand-induced osteoclastogenesis and inflammatory bone destruction","volume":"177","author":"Tan","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.intimp.2026.116342_bb0295","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.20.02754","article-title":"ROCK2 inhibition with Belumosudil (KD025) for the treatment of chronic graft-versus-host disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"35","key":"10.1016\/j.intimp.2026.116342_bb0300","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116342_bb0305","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.41666","article-title":"Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis","volume":"73","author":"Yokota","year":"2021","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2026.116342_bb0310","doi-asserted-by":"crossref","DOI":"10.36922\/OR025040004","article-title":"Advancing organoid development with 3D bioprinting","volume":"1","author":"Ma","year":"2025","journal-title":"Organoid Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116342_bb0315","first-page":"236","article-title":"The use of hydrogel microspheres as cell and drug delivery carriers for bone, cartilage, and soft tissue regeneration","volume":"5","author":"Lin","year":"2024","journal-title":"Biomater Transl."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:38:42Z","timestamp":1772599122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":63,"alternative-id":["S1567576926001864"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116342","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of ROCK2 impedes osteoclastogenesis through Src-Ca2+-NFATc1 signaling pathway and alleviates ovariectomy-induced bone loss","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116342"}}